Associated Papers
Installation of Dominant-Negative Mutations in FAS and TGFβR2 via Base Editing in Primary T Cells.
Wick BJ et al.
Biorxiv : the Preprint Server for Biology, 2025
41000687 (PubMed )
Supplement: media-1.pdf
Genomic characterization of lymphomas in patients with inborn errors of immunity.
Ye X et al.
Blood Advances, 2022
35687490 (PubMed )
Supplement: advancesADV2021006654-suppl12.xlsx › Blad1
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V et al.
Virchows Archiv : an International Journal of Pathology, 2022
34494161 (PubMed )
Supplement: 428_2021_3186_MOESM22_ESM.xlsx › Tabelle3
A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease.
Baker TS et al.
Blood Advances, 2018
The expanding spectrum of the autoimmune lymphoproliferative syndromes.
Oliveira JB
Current Opinion in Pediatrics, 2013
Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.
Lambotte O et al.
Haematologica, 2013
Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Hsu AP et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2012
Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion.
Dimopoulou MN et al.
Bone Marrow Transplantation, 2007
Select a paper to view details